GSK plc (LON:GSK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,418.00
-44.50 (-3.04%)
Jul 31, 2025, 6:21 PM BST

GSK plc Company Description

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer.

It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus.

Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions.

It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022.

GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

GSK plc
GSK plc logo
CountryUnited Kingdom
Founded1715
IndustryDrug Manufacturers - General
SectorHealthcare
Employees68,629
CEOEmma Walmsley

Contact Details

Address:
79 New Oxford Street
London, WC1A 1DG
United Kingdom
Phone44 20 8047 5000
Websitegsk.com

Stock Details

Ticker SymbolGSK
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyGBP
ISIN NumberGB00BN7SWP63
SIC Code2834

Key Executives

NamePosition
Sally JacksonSenior Vice President of Global Communications and Chief Executive Officer Office
Emma Natasha WalmsleyChief Executive Officer and Director
Julie Belita Brown A.C.A.Chief Financial Officer and Executive Director
Dr. Jesse L. Goodman M.D., M.P.H.Scientific and Medical Expert
Shobie RamakrishnanChief Digital and Technology Officer
Tony WoodChief Scientific Officer and Head of Research & Development
Constantin FestSenior Vice President and Head of Investor Relations
James FordSenior Vice President and Group General Counsel of Legal & Compliance
David Simon Redfern BSc (Hons), CAPresident of Corporate Development
Diana ConradChief People Officer